RealReal [REAL] vs Myt Netherlands [MYTE] Detailed Stock Comparison
RealReal
NASDAQ
Loading...
Myt Netherlands
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: RealReal wins in 10 metrics, Myt Netherlands wins in 8 metrics, with 0 ties. RealReal appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | RealReal | Myt Netherlands | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -4.65 | -25.34 | Myt Netherlands |
| Price-to-Book Ratio | -1.92 | 1.61 | RealReal |
| Debt-to-Equity Ratio | -1.50 | 21.21 | RealReal |
| PEG Ratio | -22.15 | 27.29 | RealReal |
| EV/EBITDA | -55.96 | 66.44 | RealReal |
| Profit Margin (TTM) | -6.60% | -3.99% | Myt Netherlands |
| Operating Margin (TTM) | -7.98% | 3.19% | Myt Netherlands |
| EBITDA Margin (TTM) | N/A | 3.19% | N/A |
| Return on Equity | 32.94% | -8.21% | RealReal |
| Return on Assets (TTM) | -7.71% | 0.41% | Myt Netherlands |
| Free Cash Flow (TTM) | $798,000 | $-1.79M | RealReal |
| 1-Year Return | 198.53% | 118.62% | RealReal |
| Price-to-Sales Ratio (TTM) | 1.06 | 1.18 | RealReal |
| Enterprise Value | $1.02B | $844.97M | RealReal |
| EV/Revenue Ratio | 1.65 | 0.81 | Myt Netherlands |
| Gross Profit Margin (TTM) | 75.00% | 44.75% | RealReal |
| Revenue per Share (TTM) | $6 | $10 | Myt Netherlands |
| Earnings per Share (Diluted) | $-1.08 | $-0.46 | Myt Netherlands |
| Beta (Stock Volatility) | 2.46 | 1.09 | Myt Netherlands |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
RealReal vs Myt Netherlands Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| RealReal | 3.05% | 4.10% | 37.39% | 52.92% | 2.01% | -17.48% |
| Myt Netherlands | 1.73% | 0.49% | 8.30% | -13.93% | -26.93% | 9.89% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| RealReal | 198.53% | 257.71% | -50.37% | -71.90% | -71.90% | -71.90% |
| Myt Netherlands | 118.62% | -39.43% | -75.68% | -75.68% | -75.68% | -75.68% |
Performance & Financial Health Analysis: RealReal vs Myt Netherlands
| Metric | REAL | MYTE |
|---|---|---|
| Market Information | ||
| Market Cap | $651.43M | $1.04B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 2,746,770 | 140,280 |
| 90 Day Avg. Volume | 2,701,557 | 121,245 |
| Last Close | $8.12 | $8.22 |
| 52 Week Range | $2.24 - $11.38 | $3.22 - $12.50 |
| % from 52W High | -28.62% | -34.24% |
| All-Time High | $30.22 (Feb 22, 2021) | $36.25 (Jan 18, 2021) |
| % from All-Time High | -73.13% | -77.32% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.11% | 0.13% |
| Quarterly Earnings Growth | 0.11% | 0.04% |
| Financial Health | ||
| Profit Margin (TTM) | -0.07% | -0.04% |
| Operating Margin (TTM) | -0.08% | 0.03% |
| Return on Equity (TTM) | 0.33% | -0.08% |
| Debt to Equity (MRQ) | -1.50 | 21.21 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-2.97 | $4.76 |
| Cash per Share (MRQ) | $1.23 | $0.16 |
| Operating Cash Flow (TTM) | $2.04M | $-9,232,541 |
| Levered Free Cash Flow (TTM) | $-2,073,125 | $30.78M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: RealReal vs Myt Netherlands
| Metric | REAL | MYTE |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -4.65 | -25.34 |
| Forward P/E | -22.15 | 27.29 |
| PEG Ratio | -22.15 | 27.29 |
| Price to Sales (TTM) | 1.06 | 1.18 |
| Price to Book (MRQ) | -1.92 | 1.61 |
| Market Capitalization | ||
| Market Capitalization | $651.43M | $1.04B |
| Enterprise Value | $1.02B | $844.97M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.65 | 0.81 |
| Enterprise to EBITDA | -55.96 | 66.44 |
| Risk & Other Metrics | ||
| Beta | 2.46 | 1.09 |
| Book Value per Share (MRQ) | $-2.97 | $4.76 |
Financial Statements Comparison: RealReal vs Myt Netherlands
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | REAL | MYTE |
|---|---|---|
| Revenue/Sales | $160.03M | $242.51M |
| Cost of Goods Sold | $40.01M | $133.98M |
| Gross Profit | $120.02M | $108.53M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $-12.77M | $-3.39M |
| EBITDA | $-2.41M | $-1.53M |
| Pre-Tax Income | $62.50M | $-6.39M |
| Income Tax | $95,000 | $-898,000 |
| Net Income (Profit) | $62.40M | $-5.49M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | REAL | MYTE |
|---|---|---|
| Cash & Equivalents | $139.60M | $14.24M |
| Total Current Assets | $208.15M | $445.93M |
| Total Current Liabilities | $239.99M | $240.53M |
| Long-Term Debt | $454.75M | $37.09M |
| Total Shareholders Equity | $-336.07M | $415.95M |
| Retained Earnings | $-1.19B | $-146.47M |
| Property, Plant & Equipment | $73.97M | $78.39M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | REAL | MYTE |
|---|---|---|
| Operating Cash Flow | $59.53M | $31.74M |
| Capital Expenditures | $-4.71M | N/A |
| Free Cash Flow | $-35.85M | $18.17M |
| Debt Repayment | N/A | $-2.31M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | REAL | MYTE |
|---|---|---|
| Shares Short | 20.20M | 630,461 |
| Short Ratio | 7.89 | 2.42 |
| Short % of Float | 0.18% | 0.04% |
| Average Daily Volume (10 Day) | 2,746,770 | 140,280 |
| Average Daily Volume (90 Day) | 2,701,557 | 121,245 |
| Shares Outstanding | 111.24M | 85.27M |
| Float Shares | 89.18M | 17.78M |
| % Held by Insiders | 0.12% | 0.86% |
| % Held by Institutions | 0.91% | 0.13% |
Dividend Analysis & Yield Comparison: RealReal vs Myt Netherlands
| Metric | REAL | MYTE |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |